NNVC שולי הרווח הגולמי nanoviricides.com

NNVC (NanoViricides, Inc.) - סמל מסחרי של החברה

The growth potential of NanoViricides, Inc. (NNVC) is based on the commercialization of "nanotraps" to combat severe infections through government procurement. The operating gross margin illustrates the dynamics of this profitability, where 0.00 shows the current value of the metric. The development of the TheraCour platform and success in clinical trials are driving the asset, while internal financial stability allows the company to ignore external macroeconomic fluctuations.

NNVC: שולי רווח גולמי NanoViricides, Inc. 04.07.2022 - 20.11.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור NanoViricides, Inc. (NNVC)

- ציטוטים ותחזית אנליסטים:
הערכת שווי פונדמנטלית:NNVC, NanoViricides, Inc.
מוצרים מיוצרים של NanoViricides Corp

For NanoViricides, Inc. (NNVC), which is developing nanotechnological drugs currently in clinical trials, controlling the cost efficiency of prototype creation is critical. This indicator measures the portion of revenue remaining after deducting direct production costs, allowing for an assessment of the business model's scalability. By analyzing the gross margin level, an investor can promptly detect rising costs of goods sold or operational inefficiencies prior to the publication of quarterly reports.